| 1 | 7705033 | Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae. | Diagn Microbiol Infect Dis | 1994 Dec |
2 |
| 2 | 7871780 | [A novel extended-spectrum beta-lactamase in a ceftazidime-resistant isolate of E. coli]. | Wei Sheng Wu Xue Bao | 1994 Oct |
9 |
| 3 | 8815106 | Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. | J Clin Microbiol | 1996 Apr |
3 |
| 4 | 8818874 | Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen. | J Clin Microbiol | 1996 Aug |
10 |
| 5 | 9925542 | Diversification of Escherichia coli expressing an SHV-type extended-spectrum beta-lactamase (ESBL) during a hospital outbreak: emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephalosporins. | Antimicrob Agents Chemother | 1999 Feb |
2 |
| 6 | 10234838 | Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum beta-lactamase. | FEMS Microbiol Lett | 1999 May 1 |
2 |
| 7 | 10705053 | Screening and confirmatory testing for extended spectrum beta-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates. | Diagn Microbiol Infect Dis | 2000 Feb |
2 |
| 8 | 10741001 | [A SHV-derived extended-spectrum beta-lactamase (SHV-12) produced by an Escherichia coli recovered from wound abscess in post operative case with rectal carcinoma]. | Kansenshogaku Zasshi | 2000 Feb |
2 |
| 9 | 10746193 | [Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria]. | Jpn J Antibiot | 1999 Sep |
4 |
| 10 | 10752694 | Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong. | APMIS | 2000 Mar |
1 |
| 11 | 10837447 | Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. | J Antimicrob Chemother | 2000 Jun |
1 |
| 12 | 10957579 | Spectrum and transferability of beta-lactam resistance in hospital strains of Enterobacter isolated in Bratislava and Innsbruck. | Int J Antimicrob Agents | 2000 Sep |
1 |
| 13 | 11097713 | Bacterial Pathogens Isolated from Patients with Bloodstream Infections in Latin America, 1997: Frequency of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program. | Braz J Infect Dis | 1999 Jun |
1 |
| 14 | 11146252 | Cefpodoxime screening of Escherichia coli and Klebsiella spp. by Vitek for detection of organisms producing extended-spectrum beta-lactamases. | Diagn Microbiol Infect Dis | 2000 Dec |
1 |
| 15 | 11320450 | Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. | Clin Infect Dis | 2001 May 15 |
5 |
| 16 | 11376058 | Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. | J Clin Microbiol | 2001 Jun |
7 |
| 17 | 11442343 | Detection and typing of extended-spectrum beta-lactamases in clinical isolates of the family Enterobacteriaceae in a medical center in Turkey. | Microb Drug Resist | 2001 Summer |
3 |
| 18 | 11502518 | SHV-16, a beta-lactamase with a pentapeptide duplication in the omega loop. | Antimicrob Agents Chemother | 2001 Sep |
1 |
| 19 | 11565067 | Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. | Clin Infect Dis | 2001 Oct 15 |
1 |
| 20 | 11673032 | Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. | Int J Antimicrob Agents | 2001 Sep |
1 |
| 21 | 11758235 | [Clinical analysis of nosocomial infection of extended spectrum beta-lactamase-producing bacteria]. | Zhonghua Nei Ke Za Zhi | 2001 Sep |
18 |
| 22 | 11766406 | [New orally active penem antibiotic: Farom]. | Yakugaku Zasshi | 2001 Dec |
5 |
| 23 | 11794426 | Extended-spectrum beta-lactamases: frequency, risk factors, and outcomes. | Pharmacotherapy | 2002 Jan |
1 |
| 24 | 11929691 | Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). | Diagn Microbiol Infect Dis | 2002 Mar |
6 |
| 25 | 11959586 | Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. | Antimicrob Agents Chemother | 2002 May |
2 |
| 26 | 12052629 | Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infections. | Diagn Microbiol Infect Dis | 2002 May |
2 |
| 27 | 12373483 | Properties of extended-spectrum beta-lactamases constructed by site-directed mutagenesis. | J Infect Chemother | 2002 Sep |
5 |
| 28 | 12445009 | Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection. | Clin Microbiol Infect | 2002 Nov |
3 |
| 29 | 12517841 | Occurrence and phenotypic characteristics of extended-spectrum beta-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests. | J Clin Microbiol | 2003 Jan |
12 |
| 30 | 12532575 | Susceptibility patterns of Escherichia coli: prevalence of multidrug-resistant isolates and extended spectrum beta-lactamase phenotype. | J Pak Med Assoc | 2002 Sep |
7 |
| 31 | 12558458 | Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. | Drugs | 2003 |
4 |
| 32 | 12709334 | Pharmacokinetics-pharmacodynamics of cefepime and piperacillin-tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: report from the ARREST program. | Antimicrob Agents Chemother | 2003 May |
1 |
| 33 | 12721319 | Prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. | J Med Microbiol | 2003 May |
3 |
| 34 | 12806752 | Extended-spectrum beta-lactamase producing enterobacteriaceae in a tertiary care hospital in Trinidad and Tobago. | West Indian Med J | 2003 Mar |
1 |
| 35 | 12812716 | Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum beta-lactamases isolated in Japan. | Diagn Microbiol Infect Dis | 2003 Jun |
3 |
| 36 | 12843054 | Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE. | J Clin Microbiol | 2003 Jul |
5 |
| 37 | 12925113 | Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in Europe. | Clin Microbiol Infect | 2003 Jul |
2 |
| 38 | 14594340 | Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period. | Pharmacotherapy | 2003 Oct |
1 |
| 39 | 14606607 | Comparison of the E-test method with an automated bacterial identification and antimicrobial susceptibility detection system for screening extended-spectrum beta-lactamase producers. | Scand J Infect Dis | 2003 |
2 |
| 40 | 14628571 | [Characteristics and clinical value of extended-spectrum beta-lactamases]. | Antibiot Khimioter | 2003 |
3 |
| 41 | 14706090 | Relationship between ciprofloxacin resistance and extended-spectrum beta-lactamase production in Escherichia coli and Klebsiella pneumoniae strains. | Clin Microbiol Infect | 2004 Jan |
1 |
| 42 | 15116574 | [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2002]. | Jpn J Antibiot | 2004 Feb |
1 |
| 43 | 15164964 | Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy. | Int J Antimicrob Agents | 2004 Mar |
1 |
| 44 | 15256035 | Detection of extended-spectrum beta-lactamase-producing, multidrug-resistant environmental isolates of Escherichia coli that bind to human bladder cells. | Microb Drug Resist | 2004 Summer |
1 |
| 45 | 15301679 | Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria. | Clin Microbiol Infect | 2004 Aug |
3 |
| 46 | 15312399 | [Plasmid-mediated cephalosporinase among extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae]. | Zhonghua Nei Ke Za Zhi | 2004 Jul |
1 |
| 47 | 15471997 | Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria. | J Antimicrob Chemother | 2004 Nov |
7 |
| 48 | 15472339 | Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. | J Clin Microbiol | 2004 Oct |
2 |
| 49 | 15500745 | [Identification and expression of blaCTX-M-14 and blaCTX-M-24]. | Zhonghua Yi Xue Za Zhi | 2004 Sep 2 |
3 |
| 50 | 15561828 | Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. | Antimicrob Agents Chemother | 2004 Dec |
2 |